Artelo Biosciences (ARTL) News Today → This 1 Biotech Stock has been shocking the markets (From Huge Alerts) (Ad) Free ARTL Stock Alerts $1.33 +0.04 (+3.11%) (As of 05/8/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative SourceHeadlineComparing Artelo Biosciences (NASDAQ:ARTL) and Genus (OTCMKTS:GENSF)americanbankingnews.com - May 3 at 2:42 AMArtelo Biosciences Announces Publication of Peer-Reviewed Article Highlighting FABP7 as a Promising Novel Target in Cancer Therapyglobenewswire.com - April 23 at 8:30 AMArtelo Biosciences CEO to Appear on Benzinga All Access on April 23rd at Approximately 10:50 AM Eastern Timeglobenewswire.com - April 22 at 8:30 AMRecap: Artelo Biosciences Q4 Earningsbenzinga.com - March 25 at 1:13 PMArtelo Biosciences GAAP EPS of -$3.14 misses by $0.58msn.com - March 25 at 1:13 PMArtelo Biosciences Reports Fiscal 2023 Year-End Financial Results and Provides Business Updateglobenewswire.com - March 25 at 8:00 AMArtelo Biosciences Selected as a Finalist in Johnson & Johnson's Innovation Challengeglobenewswire.com - March 12 at 9:15 AMArtelo Biosciences, Inc.: Artelo Biosciences to Present at the Winter Wrap-Up MicroCap Rodeo Conference on February 20thfinanznachrichten.de - February 15 at 10:34 AMArtelo Biosciences Announces Selection of Worldwide Clinical Trials as Clinical Research Organization to Support First-in-Human Study of ART26.12finance.yahoo.com - January 8 at 3:07 PMArtelo Biosciences Presents New Preclinical Data on ART12.11 at the 4th Annual Med-Cannabis 2023 Conference in Germanyfinance.yahoo.com - December 5 at 9:22 AMPromising Developments in Artelo Biosciences’ Cancer Therapies Drive Buy Rating Recommendationmarkets.businessinsider.com - November 16 at 1:30 PMArtelo Biosciences GAAP EPS of -$0.83 misses by $0.18msn.com - November 13 at 3:50 PMArtelo Biosciences Reports Third Quarter 2023 Financial Results and Provides Business Updatefinance.yahoo.com - November 13 at 10:11 AMArtelo Biosciences Inc ARTLmorningstar.com - November 7 at 11:39 PMArtelo Biosciences to Present Preclinical Data Showcasing Research on ART26.12 and ART12.11 in Anxiety and Depression at Neuroscience 2023finance.yahoo.com - November 2 at 9:23 AMArtelo Biosciences to Present at the H.C. Wainwright 25th Annual Global Investment Conference on September 13thfinance.yahoo.com - September 5 at 11:57 AMAnalysts Offer Insights on Healthcare Companies: Larimar Therapeutics (LRMR), Artelo Biosciences (ARTL) and Unity Biotechnology (UBX)markets.businessinsider.com - August 11 at 4:35 PMArtelo Biosciences (ARTL) Receives a Buy from Ladenburg Thalmann & Co.markets.businessinsider.com - June 28 at 9:56 AMArtelo Unvails New Data On ART26.12 Demonstrating Positive Effects In Multiple Models Of Neuropathic Painmsn.com - June 27 at 12:41 PMArtelo Biosciences Announces Important New Data on ART26.12 Demonstrating Positive Effects in Multiple Models of Neuropathic Pain at the 33rd Annual International Cannabinoid Research Society Symposiumfinance.yahoo.com - June 27 at 12:41 PMAnalysts Offer Insights on Healthcare Companies: Artelo Biosciences (ARTL), Iterum Therapeutics (ITRM) and TScan Therapeutics (TCRX)markets.businessinsider.com - May 18 at 8:34 AMArtelo Biosciences: Q1 Earnings Insightsmsn.com - May 11 at 7:26 PMArtelo Biosciences Reports First Quarter 2023 Financial Results and Provides Business Updatefinance.yahoo.com - May 11 at 9:26 AMArtelo Biosciences Initiates the Phase 2a Portion of its CAReS Trial EvaluatingART27.13 for the Treatment of Cancer-Related Anorexia and Weight Lossfinance.yahoo.com - April 25 at 9:59 AMArtelo Biosciences (ARTL) Gets a Buy from Maxim Groupmarkets.businessinsider.com - April 4 at 10:22 AMArtelo Biosciences (ARTL) Gets a Buy from Ladenburg Thalmann & Co.markets.businessinsider.com - April 3 at 8:52 AMArtelo Biosciences GAAP EPS of -$3.56seekingalpha.com - April 2 at 2:33 PMArtelo Biosciences to Present at MicroCap Rodeo’s Annual Winter Wonderland – Best Ideas Virtual Investor Conference on February 22, 2023finance.yahoo.com - February 15 at 10:23 AMArtelo Biosciences Reports Third Quarter 2022 Financial Results and Provides Business Updatefinance.yahoo.com - November 8 at 11:40 AMArtelo Biosciences to Present at The LD Micro Main Event XVfinance.yahoo.com - October 18 at 12:49 PMARTL Artelo Biosciences, Inc.seekingalpha.com - October 11 at 1:29 PMArtelo Biosciences to Present at the 2022 Ladenburg Thalmann Healthcare Conference on September 29thfinance.yahoo.com - September 22 at 10:27 AMArtelo Biosciences to Present at the H.C. Wainwright 24th Annual Global Investment Conferencefinance.yahoo.com - September 7 at 11:20 AMThinking about buying stock in Bed Bath & Beyond, Chembio Diagnostics, Giga Media, Artelo Biosciences, or SNDL?morningstar.com - August 17 at 11:05 PMU.S. Stocks Open Lower; Nasdaq Down 150 Pointsmsn.com - August 17 at 6:05 PMNasdaq Falls 75 Points; Ventyx Biosciences Shares Spike Highermarkets.businessinsider.com - August 16 at 3:50 PMArtelo jumps 21% as publication highlights pre-clinical data on drug platformseekingalpha.com - August 16 at 3:50 PMArtelo Biosciences Reports Positive Pre-Clinical Results with its Novel Inhibitor to Fatty Acid Binding Protein 5finance.yahoo.com - August 16 at 10:50 AMHC Wainwright Reaffirms "Buy" Rating for Artelo Biosciences (NASDAQ:ARTL)marketbeat.com - August 12 at 8:32 AMmarketbeat.com - August 10 at 3:13 PMmarketbeat.com - August 10 at 3:04 PMmarketbeat.com - August 10 at 2:41 PMArtelo Biosciences, Inc. (ARTL)finance.yahoo.com - August 6 at 12:18 AMArtelo Biosciences Reveals Positive Pre-Clinical Results Of ART26.12, A Novel FABP5 Inhibitor, In Alleviating Chemotherapy-Induced Painmsn.com - June 27 at 3:57 PMArtelo Biosciences Presents Positive Pre-Clinical Results of ART26.12, a Novel FABP5 Inhibitor, in Alleviating Chemotherapy-Induced Painfinance.yahoo.com - June 27 at 9:55 AMArtelo Biosciences Selected for Oral Presentation at the 32nd Annual ICRS Symposium in Galway, Irelandfinance.yahoo.com - June 24 at 6:23 PMArtelo Biosciences Inc - Stock Newsmorningstar.com - June 3 at 8:32 AMArtelo Biosciences, Inc.: Artelo Biosciences to Present at MicroCap Rodeo's Spring into Action Best Ideas Virtual Conference on May 16thfinanznachrichten.de - May 14 at 11:08 PMArtelo Biosciences to Present at MicroCap Rodeo's Spring into Action Best Ideas Virtual Conference on May 16thstockhouse.com - May 13 at 5:10 PMArtelo Biosciences to Present at Investor Summit Group's Q2 In-Person Conference in New Yorkyahoo.com - April 25 at 8:28 AM Get Artelo Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ARTL and its competitors with MarketBeat's FREE daily newsletter. Email Address The 2024 Gold Rush: Unleashing Market Potential (Ad)Welcome to the financial rollercoaster of 2024, where inflation is persistent, stock markets are overinflated and volatile, global conflicts are intensifying, and the national debt is reaching new heights. Get your free information kit NOW, before it's too late. ARTL Media Mentions By Week ARTL Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ARTL News Sentiment▼0.000.36▲Average Medical News Sentiment ARTL News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ARTL Articles This Week▼10▲ARTL Articles Average Week Get Artelo Biosciences News Delivered to You Automatically Sign up to receive the latest news and ratings for ARTL and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Ensysce Biosciences News Longeveron News Soligenix News Exicure News Tharimmune News Evoke Pharma News Revelation Biosciences News GT Biopharma News Alzamend Neuro News Phio Pharmaceuticals News Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ARTL) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Artelo Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
